STING-Dependent Recognition of Cyclic di-AMP Mediates Type I Interferon Responses during Chlamydia trachomatis Infection

ABSTRACT STING (stimulator of interferon [IFN] genes) initiates type I IFN responses in mammalian cells through the detection of microbial nucleic acids. The membrane-bound obligate intracellular bacterium Chlamydia trachomatis induces a STING-dependent type I IFN response in infected cells, yet the IFN-inducing ligand remains unknown. In this report, we provide evidence that Chlamydia synthesizes cyclic di-AMP (c-di-AMP), a nucleic acid metabolite not previously identified in Gram-negative bacteria, and that this metabolite is a prominent ligand for STING-mediated activation of IFN responses during infection. We used primary mouse lung fibroblasts and HEK293T cells to compare IFN-β responses to Chlamydia infection, c-di-AMP, and other type I IFN-inducing stimuli. Chlamydia infection and c-di-AMP treatment induced type I IFN responses in cells expressing STING but not in cells expressing STING variants that cannot sense cyclic dinucleotides but still respond to cytoplasmic DNA. The failure to induce a type I IFN response to Chlamydia and c-di-AMP correlated with the inability of STING to relocalize from the endoplasmic reticulum to cytoplasmic punctate signaling complexes required for IFN activation. We conclude that Chlamydia induces STING-mediated IFN responses through the detection of c-di-AMP in the host cell cytosol and propose that c-di-AMP is the ligand predominantly responsible for inducing such a response in Chlamydia-infected cells. IMPORTANCE This study shows that the Gram-negative obligate pathogen Chlamydia trachomatis, a major cause of pelvic inflammatory disease and infertility, synthesizes cyclic di-AMP (c-di-AMP), a nucleic acid metabolite that thus far has been described only in Gram-positive bacteria. We further provide evidence that the host cell employs an endoplasmic reticulum (ER)-localized cytoplasmic sensor, STING (stimulator of interferon [IFN] genes), to detect c-di-AMP synthesized by Chlamydia and induce a protective IFN response. This detection occurs even though Chlamydia is confined to a membrane-bound vacuole. This raises the possibility that the ER, an organelle that innervates the entire cytoplasm, is equipped with pattern recognition receptors that can directly survey membrane-bound pathogen-containing vacuoles for leaking microbe-specific metabolites to mount type I IFN responses required to control microbial infections. This study shows that the Gram-negative obligate pathogen Chlamydia trachomatis, a major cause of pelvic inflammatory disease and infertility, synthesizes cyclic di-AMP (c-di-AMP), a nucleic acid metabolite that thus far has been described only in Gram-positive bacteria. We further provide evidence that the host cell employs an endoplasmic reticulum (ER)-localized cytoplasmic sensor, STING (stimulator of interferon [IFN] genes), to detect c-di-AMP synthesized by Chlamydia and induce a protective IFN response. This detection occurs even though Chlamydia is confined to a membrane-bound vacuole. This raises the possibility that the ER, an organelle that innervates the entire cytoplasm, is equipped with pattern recognition receptors that can directly survey membrane-bound pathogen-containing vacuoles for leaking microbe-specific metabolites to mount type I IFN responses required to control microbial infections.

[1]  C. M. Short,et al.  MPYS, a Novel Membrane Tetraspanner, Is Associated with Major Histocompatibility Complex Class II and Mediates Transduction of Apoptotic Signals , 2008, Molecular and Cellular Biology.

[2]  E. Straube,et al.  Interferon-beta induction by Chlamydia pneumoniae in human smooth muscle cells. , 2001, FEMS immunology and medical microbiology.

[3]  Courtney R. Plumlee,et al.  The overlapping host responses to bacterial cyclic dinucleotides. , 2012, Microbes and infection.

[4]  Karl-Peter Hopfner,et al.  Structural biochemistry of a bacterial checkpoint protein reveals diadenylate cyclase activity regulated by DNA recombination intermediates. , 2008, Molecular cell.

[5]  Zhijian J. Chen,et al.  Cyclic GMP-AMP Synthase Is a Cytosolic DNA Sensor That Activates the Type I Interferon Pathway , 2013, Science.

[6]  Y. Li,et al.  The adaptor protein MITA links virus-sensing receptors to IRF3 transcription factor activation. , 2008, Immunity.

[7]  G. Barber,et al.  STING regulates intracellular DNA-mediated, type I interferon-dependent innate immunity , 2009, Nature.

[8]  V. Hornung,et al.  RIG-I-dependent sensing of poly(dA:dT) through the induction of an RNA polymerase III–transcribed RNA intermediate , 2009, Nature Immunology.

[9]  Elaine Y Fukuda,et al.  Up-Regulation of the JAK/STAT1 Signal Pathway during Chlamydia trachomatis Infection1 , 2005, The Journal of Immunology.

[10]  K. Hybiske,et al.  Mechanisms of host cell exit by the intracellular bacterium Chlamydia , 2007, Proceedings of the National Academy of Sciences.

[11]  A. Camilli,et al.  Roles of cyclic diguanylate in the regulation of bacterial pathogenesis. , 2007, Annual review of microbiology.

[12]  G. Barber,et al.  Cellular and Molecular Life Sciences REVIEW The STING pathway and regulation of innate immune signaling in response to DNA pathogens , 2022 .

[13]  R. Vance,et al.  Induction of type I interferons by bacteria , 2010, Cellular microbiology.

[14]  Helen R Saibil,et al.  Chlamydiae Assemble a Pathogen Synapse to Hijack the Host Endoplasmic Reticulum , 2012, Traffic.

[15]  Zhijian J. Chen,et al.  Identification and characterization of MAVS, a mitochondrial antiviral signaling protein that activates NF-kappaB and IRF 3. , 2005, Cell.

[16]  Yuan Tian,et al.  Cyclic di-GMP sensing via the innate immune signaling protein STING. , 2012, Molecular cell.

[17]  Wilbert A. Derbigny,et al.  Chlamydia muridarum Infection Elicits a Beta Interferon Response in Murine Oviduct Epithelial Cells Dependent on Interferon Regulatory Factor 3 and TRIF , 2006, Infection and Immunity.

[18]  M. Lehmann,et al.  Beta interferon is produced by Chlamydia trachomatis-infected fibroblast-like synoviocytes and inhibits gamma interferon-induced HLA-DR expression. , 1998, Infection and immunity.

[19]  Zhijian J. Chen,et al.  STING Specifies IRF3 Phosphorylation by TBK1 in the Cytosolic DNA Signaling Pathway , 2012, Science Signaling.

[20]  C. Waters,et al.  Quantification of high-specificity cyclic diguanylate signaling , 2012, Proceedings of the National Academy of Sciences.

[21]  R. Valdivia,et al.  Cytoplasmic lipid droplets are translocated into the lumen of the Chlamydia trachomatis parasitophorous vacuole , 2008, Proceedings of the National Academy of Sciences.

[22]  E. Straube,et al.  Role of Interferon-Stimulated Gene Factor 3γ and Beta Interferon in HLA Class I Enhancement in Synovial Fibroblasts upon Infection with Chlamydia trachomatis , 2002, Infection and Immunity.

[23]  R. Valdivia,et al.  The Obligate Intracellular Pathogen Chlamydia trachomatis Targets Host Lipid Droplets , 2006, Current Biology.

[24]  M. Starnbach,et al.  Chlamydia muridarum Evades Growth Restriction by the IFN-γ-Inducible Host Resistance Factor Irgb101 , 2008, The Journal of Immunology.

[25]  R. Heinzen,et al.  The Chlamydia trachomatis parasitophorous vacuolar membrane is not passively permeable to low-molecular-weight compounds , 1997, Infection and immunity.

[26]  D. Portnoy,et al.  Mycobacterium tuberculosis activates the DNA-dependent cytosolic surveillance pathway within macrophages. , 2012, Cell host & microbe.

[27]  Sigal Ben-Yehuda,et al.  c‐di‐AMP reports DNA integrity during sporulation in Bacillus subtilis , 2011, EMBO reports.

[28]  T. Darville,et al.  Stimulator of IFN Gene Is Critical for Induction of IFN-β during Chlamydia muridarum Infection , 2010, The Journal of Immunology.

[29]  D. Portnoy,et al.  Hyperinduction of Host Beta Interferon by a Listeria monocytogenes Strain Naturally Overexpressing the Multidrug Efflux Pump MdrT , 2012, Infection and Immunity.

[30]  Zhijian J. Chen,et al.  Identification and Characterization of MAVS, a Mitochondrial Antiviral Signaling Protein that Activates NF-κB and IRF3 , 2005, Cell.

[31]  E. Straube,et al.  Interferon-β induction by Chlamydia pneumoniae in human smooth muscle cells , 2001 .

[32]  T. Giese,et al.  Quantitative Expression of Toll-Like Receptor 1–10 mRNA in Cellular Subsets of Human Peripheral Blood Mononuclear Cells and Sensitivity to CpG Oligodeoxynucleotides1 , 2002, The Journal of Immunology.

[33]  S. Kakinuma,et al.  Hepatitis C virus NS4B protein targets STING and abrogates RIG‐I–mediated type I interferon‐dependent innate immunity , 2013, Hepatology.

[34]  Lei Jin,et al.  MPYS Is Required for IFN Response Factor 3 Activation and Type I IFN Production in the Response of Cultured Phagocytes to Bacterial Second Messengers Cyclic-di-AMP and Cyclic-di-GMP , 2011, The Journal of Immunology.

[35]  T. Darville,et al.  Chlamydia trachomatis Induces Expression of IFN-γ-Inducible Protein 10 and IFN-β Independent of TLR2 and TLR4, but Largely Dependent on MyD881 , 2005, The Journal of Immunology.

[36]  Xiaoping Zhou,et al.  ERIS, an endoplasmic reticulum IFN stimulator, activates innate immune signaling through dimerization , 2009, Proceedings of the National Academy of Sciences.

[37]  Ryan M. O’Connell,et al.  Type I Interferon Production Enhances Susceptibility to Listeria monocytogenes Infection , 2004, The Journal of experimental medicine.

[38]  P. Kovarik,et al.  Type I Interferon Production Induced by Streptococcus pyogenes-Derived Nucleic Acids Is Required for Host Protection , 2011, PLoS pathogens.

[39]  J. Stülke,et al.  Cyclic Di-AMP Homeostasis in Bacillus subtilis , 2012, The Journal of Biological Chemistry.

[40]  Yong‐jun Liu,et al.  The helicase DDX41 senses intracellular DNA mediated by the adaptor STING in dendritic cells , 2011, Nature Immunology.

[41]  U. Römling Great Times for Small Molecules: c-di-AMP, a Second Messenger Candidate in Bacteria and Archaea , 2008, Science Signaling.

[42]  Shizuo Akira,et al.  Antiviral signaling through pattern recognition receptors. , 2006, Journal of biochemistry.

[43]  Sky W. Brubaker,et al.  The N-Ethyl-N-Nitrosourea-Induced Goldenticket Mouse Mutant Reveals an Essential Function of Sting in the In Vivo Interferon Response to Listeria monocytogenes and Cyclic Dinucleotides , 2010, Infection and Immunity.

[44]  Wilbert A. Derbigny,et al.  Identifying a Role for Toll-Like Receptor 3 in the Innate Immune Response to Chlamydia muridarum Infection in Murine Oviduct Epithelial Cells , 2011, Infection and Immunity.

[45]  R. Vance,et al.  STING and the innate immune response to nucleic acids in the cytosol , 2012, Nature Immunology.

[46]  Yoshihiro Hayakawa,et al.  STING is a direct innate immune sensor of cyclic-di-GMP , 2011, Nature.

[47]  Yasser M. Abdelrahman,et al.  The chlamydial developmental cycle. , 2005, FEMS microbiology reviews.

[48]  James C. Abbott,et al.  c-di-AMP Is a New Second Messenger in Staphylococcus aureus with a Role in Controlling Cell Size and Envelope Stress , 2011, PLoS pathogens.

[49]  D. Portnoy,et al.  c-di-AMP Secreted by Intracellular Listeria monocytogenes Activates a Host Type I Interferon Response , 2010, Science.

[50]  J. Mekalanos,et al.  Coordinated Regulation of Accessory Genetic Elements Produces Cyclic Di-Nucleotides for V. cholerae Virulence , 2012, Cell.

[51]  S. Akira,et al.  Pattern Recognition Receptors and Inflammation , 2010, Cell.

[52]  Wilbert A. Derbigny,et al.  The Chlamydia muridarum-Induced IFN-β Response Is TLR3-Dependent in Murine Oviduct Epithelial Cells , 2010, The Journal of Immunology.

[53]  G. Hartmann,et al.  RIG‐I detects infection with live Listeria by sensing secreted bacterial nucleic acids , 2012, The EMBO journal.

[54]  C. Andrews,et al.  Type I Interferon Signaling Exacerbates Chlamydia muridarum Genital Infection in a Murine Model , 2008, Infection and Immunity.

[55]  Dongwei Zhang,et al.  YybT Is a Signaling Protein That Contains a Cyclic Dinucleotide Phosphodiesterase Domain and a GGDEF Domain with ATPase Activity* , 2009, The Journal of Biological Chemistry.

[56]  Wilbert A. Derbigny,et al.  Pattern Recognition Molecules Activated by Chlamydia muridarum Infection of Cloned Murine Oviduct Epithelial Cell Lines1 , 2005, The Journal of Immunology.

[57]  H. B. Moeller,et al.  Virus-cell fusion as a trigger of innate immunity dependent on the adaptor STING , 2012, Nature Immunology.

[58]  A. Devitt,et al.  Induction of alpha/beta interferon and dependent nitric oxide synthesis during Chlamydia trachomatis infection of McCoy cells in the absence of exogenous cytokine , 1996, Infection and immunity.

[59]  H. Agaisse,et al.  The Lipid Transfer Protein CERT Interacts with the Chlamydia Inclusion Protein IncD and Participates to ER-Chlamydia Inclusion Membrane Contact Sites , 2011, PLoS pathogens.

[60]  新田 沙由梨 Hepatitis C virus NS4B protein targets STING and abrogates RIG-I-mediated type I interferon-dependent innate immunity , 2012 .

[61]  C. Elwell,et al.  Chlamydia trachomatis Co-opts GBF1 and CERT to Acquire Host Sphingomyelin for Distinct Roles during Intracellular Development , 2011, PLoS pathogens.

[62]  D. Portnoy,et al.  Mice Lacking the Type I Interferon Receptor Are Resistant to Listeria monocytogenes , 2004, The Journal of experimental medicine.

[63]  R. Dudani,et al.  Type I interferon induces necroptosis in macrophages during infection with Salmonella enterica serovar Typhimurium , 2012, Nature Immunology.

[64]  M. Ikeda,et al.  Inhibition of chlamydia trachomatis growth by human interferon-alpha: mechanisms and synergistic effect with interferon-gamma and tumor necrosis factor-alpha. , 2005, Biomedical research.

[65]  G. Zhong,et al.  Genomic transcriptional profiling of the developmental cycle of Chlamydia trachomatis , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[66]  G. Núñez,et al.  RICK/RIP2 Mediates Innate Immune Responses Induced through Nod1 and Nod2 but Not TLRs1 , 2007, The Journal of Immunology.

[67]  C. Counter,et al.  A genetically defined normal human somatic cell system to study ras oncogenesis in vivo and in vitro. , 2006, Methods in enzymology.

[68]  Laura G. Dubois,et al.  Quantitative proteomics reveals metabolic and pathogenic properties of Chlamydia trachomatis developmental forms , 2011, Molecular microbiology.

[69]  G. Barber,et al.  STING an Endoplasmic Reticulum Adaptor that Facilitates Innate Immune Signaling , 2008, Nature.

[70]  N. Low,et al.  Risk of sequelae after Chlamydia trachomatis genital infection in women. , 2010, The Journal of infectious diseases.

[71]  T. Darville,et al.  Chlamydia trachomatis induces expression of IFN-gamma-inducible protein 10 and IFN-beta independent of TLR2 and TLR4, but largely dependent on MyD88. , 2005, Journal of immunology.

[72]  R. Valdivia,et al.  cPLA2 Regulates the Expression of Type I Interferons and Intracellular Immunity to Chlamydia trachomatis* , 2010, The Journal of Biological Chemistry.

[73]  K. Ishii,et al.  Atg9a controls dsDNA-driven dynamic translocation of STING and the innate immune response , 2009, Proceedings of the National Academy of Sciences.

[74]  C. Waters,et al.  A Tangled Web: Regulatory Connections between Quorum Sensing and Cyclic Di-GMP , 2012, Journal of bacteriology.

[75]  M. Yoneyama,et al.  RNA recognition and signal transduction by RIG‐I‐like receptors , 2009, Immunological reviews.

[76]  J. Helmann,et al.  Analysis of the role of Bacillus subtilis σM in β‐lactam resistance reveals an essential role for c‐di‐AMP in peptidoglycan homeostasis , 2012, Molecular microbiology.